C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
11/2006
11/23/2006	US20060263377 Surface protein of Leptospira
11/23/2006	US20060263356 antibody binding to IL-13R alpha 1, inhibiting IL-13 bioactivity; comprising variable heavy and light chain amino acid sequences CDR1, CDR2, and CDR3; useful in the treatment of asthma and allergic diseases
11/23/2006	US20060263353 untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing the antigen; for cancers, autoimmune or inflammatory disorders
11/23/2006	US20060263345 Butyrylcholinesterase variant polypeptides with increased catalytic efficiency and methods of use
11/23/2006	US20060263334 Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
11/23/2006	DE102005023761A1 An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide At the Lck-SH3 and SH3 domain binding peptides Hck
11/23/2006	CA2609150A1 Compositions, methods and kits for real-time nucleic acid analysis in live cells
11/23/2006	CA2609067A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	CA2609062A1 Oligonucleotides or their functional homologues, a composition comprising the same and a method of treating b cell neoplasm
11/22/2006	EP1724353A2 Methods of forming protein-linked lipidic microparticles
11/22/2006	EP1724349A1 TIE Ligand Homologues
11/22/2006	EP1724348A2 Molecular tagging system
11/22/2006	EP1724343A1 Dna enzyme and method of controlling the activity thereof
11/22/2006	EP1724284A2 GLP-1 fusion proteins
11/22/2006	EP1723950A2 Method of treating dopaminergic gaba-nergic disorders
11/22/2006	EP1723258A1 Method of prognosis of metastasis by detection of fra12e fragile site within the smrt gene/locus at chromosome 12q24
11/22/2006	EP1723252A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients
11/22/2006	EP1723245A2 Glutamine-rich maize seed protein and promoter
11/22/2006	EP1723227A2 Nicotinamide riboside kinase compositions and methods for using the same
11/22/2006	EP1723162A2 Anti-microrna oligonucleotide molecules
11/22/2006	EP1723161A1 Radiolabeled compounds and compositions, their precursors and methods for their production
11/22/2006	EP1723160A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients
11/22/2006	EP1722823A2 Pharmaceutical composition
11/22/2006	EP1722808A2 Egf receptor epitode peptides and uses thereof
11/22/2006	EP1722760A2 Delivery of genes encoding short hairpin rna using receptor-specific nanocontainers
11/22/2006	EP1266025B1 Protein scaffolds for antibody mimics and other binding proteins
11/22/2006	EP1044281B1 Method for in vitro amplification of circular dna
11/22/2006	EP0935415B1 In vitro methods for delivering nucleic acids into a cell
11/22/2006	EP0825996B1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use
11/22/2006	CN1867681A Apparatus and methods for detecting nucleic acid in biological samples
11/22/2006	CN1867671A Compositions and methods for prognosis and therapy of liver cancer
11/22/2006	CN1865937A Real-time fluorescent quantitative detection method for simultaneous detection of A-type and B-type influenza virus and kit therefor
11/22/2006	CN1865430A Engineered bacteria Pichia pastoris for high yield of insulinotropic hormone and its construction method
11/22/2006	CN1865275A Artificial single-chain deoxynucleotide having therapeutic effect to human B cell tumour
11/22/2006	CN1864747A Method for preparing active carrier vaccine of avian Chlamydia psittaci
11/22/2006	CN1285734C One section human type mycoplasmas DNA sequence (1) specificity and its application
11/22/2006	CN1285728C Nucleotide to 0-antigen specificity of escherichia coli 0154 type
11/22/2006	CN1285727C O-antigen specific nucleotide of E.coli 0139 type
11/22/2006	CN1285726C Nucleotide specific against 0-antigen of shigella dysenteria 3, colibacillus 0124 and 0164
11/22/2006	CN1285606C Nucleotide specific for shigella bodyii 2 O-antigen
11/21/2006	US7138568 Expression vector coding insecticidal protein for use in the transformation and generation of moth resistant leafy plants
11/21/2006	US7138567 Ga20 oxidase from rice and uses thereof
11/21/2006	US7138563 Gene of aluminum-activated malate transporter of a plant and a protein encoded by the gene
11/21/2006	US7138518 Liquid chromatographic separation of polynucleotides
11/21/2006	US7138517 Sugar modified oligonucleotides
11/21/2006	US7138516 in hybridization assays; can distinguish between target and non-target species; probes for bacteria, fungi such as Mycobacterium avium, tuberculosis-complex bacteria, Legionella, Salmonella, Chlamydia trachomatis, Campylobacter, Proteus mirabilis, Enterococcus
11/21/2006	US7138515 Translational activity-promoting higher-order structure
11/21/2006	US7138513 Genes encoding for genetic stability, gene expression and folding proteins
11/21/2006	US7138511 Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
11/21/2006	US7138510 Cloning sequencing and characterization of two cell death genes and uses therefor
11/21/2006	US7138509 GANP protein
11/21/2006	US7138507 primers for amplification of GST-pi mRNA in fixed and paraffin-embedded (FPE) tumor tissue; use in pharmacogenetics
11/21/2006	US7138506 Universal microarray system
11/21/2006	US7138505 of given sequence, for the preparation of human Factor VIIIC, which is absent or defective in individuals with the hereditary bleeding disorder hemophilia A; host cells and expression vectors
11/21/2006	US7138500 Antibodies to human 4-1BB
11/21/2006	US7138498 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of
11/21/2006	US7138497 Genetic engineering; crosslinking polypeptide on carrier
11/21/2006	US7138492 Promoting survival of substantia nigra neuronal cells by contacting with a trophic amount of a ptc therapeutic; mimics hedgehog-mediated patched signal transduction; treating or preventing Parkinson's Disease
11/21/2006	US7138383 That retains the high RNA binding affinity of the parent oligonucleotide N3' --> P5' phosphoramidates and exhibits a much higher acid stability; inhibiting human telomerase enzyme activity
11/21/2006	US7138382 Compositions and methods for drug delivery using pH sensitive molecules
11/21/2006	US7138380 Transgenic animals and cell lines for screening drugs effective for the treatment or prevention of Alzheimer's disease
11/21/2006	US7138378 Preparing a suppression effector and replacement nucleic acid that have modifications in one or more third base (wobble) positions so that replacement nucleic acids still code for the wild type or equivalent amino acids
11/21/2006	US7138278 Transformation vector which comprises regulatory sequences for expressing trangenes in plants; disease resistant plants
11/21/2006	US7138277 Genes encoding plant transcription factors
11/21/2006	US7138263 Endoglucanase enzyme NCE5 and cellulase preparations containing the same
11/21/2006	US7138262 High mannose proteins and methods of making high mannose proteins
11/21/2006	US7138259 PDEs and uses thereof
11/21/2006	US7138254 Methods and apparatus for performing submicroliter reactions with nucleic acids or proteins
11/21/2006	US7138242 Replication primer sequences for identifying ligand-binding domains for detection of neuron odorants, toxic odors and which can be used to manipulate odor response in animals
11/21/2006	US7138232 Detcting preferential particles in biological fluid; obtain fluid sample, incubate with labelled probe, detect signal from preferential biopolymers
11/21/2006	US7138231 Means and methods for monitoring protease inhibitor antiretroviral therapy and guiding therapeutic decisions in the treatment of HIV/AIDS
11/17/2006	CA2549902A1 Cd44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
11/16/2006	WO2006122205A2 Conus californicus neurotoxins
11/16/2006	WO2006121810A2 Trimeric ox40-immunoglobulin fusion protein and methods of use
11/16/2006	WO2006121773A2 Compositions and assays to detect influenza virus a and b nucleic acids
11/16/2006	WO2006121422A2 Antibodies against clostridium difficile toxins and uses thereof
11/16/2006	WO2006120992A1 Nucleic acid derivatives having phenyldiaziridine moieties and process for production thereof, nucleotide derivatives having phenyldiaziridine moieties and process for production thereof, method for analysis of protein, and process for preparation of protein
11/16/2006	WO2006120678A2 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/16/2006	WO2006119647A1 Oligonucleotides and methods of use
11/16/2006	WO2006104677A3 Antibodies that bind ov064 and methods of use therefor
11/16/2006	WO2006102643A3 Stably transformed bone marrow-derived cells and uses thereof
11/16/2006	WO2006088962A9 Replikin peptides and uses thereof
11/16/2006	WO2006083986A3 Biomarkers for tissue status
11/16/2006	WO2006073458A8 Oligonucleotides comprising a c5-modified pyrimidine
11/16/2006	WO2006060595A3 Reverse two hybrid system for identification of interaction domains
11/16/2006	WO2006051397A3 Oligonucleotide probes
11/16/2006	WO2006034228A3 Arabidopsis genes encoding proteins involved in sugar and lipid metabolism and methods of use
11/16/2006	WO2006009933A3 Cdk9 as modifier of the igf pathway and methods of use
11/16/2006	WO2005104834A3 Pain-associated gene pnpg5
11/16/2006	WO2005082020A8 Flavivirus vaccines
11/16/2006	WO2005081714A3 Use of interfering rna in the production of transgenic animals
11/16/2006	WO2004092330A3 Method of generating long nucleic acid molecules of defined sequence
11/16/2006	WO2001057190A3 Novel nucleic acids and polypeptides
11/16/2006	US20060260013 Root-specific phosphate transporter promoters
11/16/2006	US20060260009 Containing regulatory sequences whose expression results in spectrally red-shifted phytochromes that are effective in detecting far-red light in the shade; transgenic plants having shade tolerance
11/16/2006	US20060260008 vectors, transformed host cells that contain nucleic acid segments that encode the disclosed delta -endotoxin polypeptides; Bacillus thuringiensis cell
11/16/2006	US20060260004 Par-related protein promoters
11/16/2006	US20060259996 Structure-based methods and compositions useful in designing, identifying, and producing molecules which act as functional modulators of TDF-like (tissue differentiation factor) receptors; methods of detecting, preventing, and treating TDF-associated disorders
11/16/2006	US20060259995 Proteases, nucleic acids encoding them and methods for making and using them
11/16/2006	US20060259994 Cathepsin-associated genetically modified nonhuman mammal

1 ... 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 ... 899